September 6, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating The Advisory Board Company ("Advisory Board” or the "Company") (NASDAQ: ABCO), a company that provides performance-improvement software and services to the healthcare and education industries. Investors who purchased shares of Advisory Board common stock may be affected.
September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of SteadyMed Ltd. (“SteadyMed” or the “Company”) (NASDAQ: STDY).
September 1, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of DryShips Inc. (“DryShips” or the “Company”) (NASDAQ: DRYS).
August 22, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Envision Healthcare Corporation (“Envision Healthcare” or the “Company”) (NYSE: EVHC).
August 22, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Sequans Communications S.A. (“Sequans” or the “Company”) (NYSE: SQNS).
August 10, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of American Public Education, Inc. (“American Public Education” or the “Company”) (NASDAQ APEI). Investors who purchased shares of American Public Education securities may be affected.
August 8, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of GlobalSCAPE, Inc. (“GlobalSCAPE” or the “Company”) (NYSE MKT: GSB). Investors who purchased shares of GlobalSCAPE common stock may be affected.
July 27, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Arconic, Inc. (“Arconic” or the “Company”) (NYSE: ARNC). Investors who purchased shares of Arconic securities between November 4, 2013 and June 26, 2017 (the “Class Period”) may be affected.
July 19, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Ocular Therapeutix, Inc. (“Ocular Therapeutix” or the “Company”) (NASDAQ: OCUL).
June 20, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Mazor Robotics Ltd. (“Mazor” or the “Company”) (NASDAQ: MZOR).
June 16, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Booz Allen Hamilton Holding Corporation (“Booz Allen” or the “Company”) (NYSE: BAH). Investors who purchased shares of Booz Allen securities may be affected.
June 14, 2017 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Synchronoss Technologies, Inc. (“Synchronoss” or the “Company”) (NASDAQ: SNCR). Investors who purchased shares of Synchronoss securities may be affected.
May 4, 2016 – Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) has been investigating Credit Acceptance Corporation ("Credit Acceptance” or the "Company") (NASDAQ: CACC), a subprime auto lender, for potential violations of the federal securities laws. Investors who purchased shares of Credit Acceptance common stock may be affected.
| Company | Ticker | Class Period | Deadline | Administrator | |
|---|---|---|---|---|---|
| Xencor, Inc. | XNCR | On behalf of all former holders of Xencor, Inc.'s (the "Company") Series A-E preferred stock whose shares were converted to A-1 stock in the Recapitalization. | 5/13/17 | Strategic Claims Services | |
| Molycorp, Inc. | MCP | 2/21/2012 - 10/15/2013 | 5/18/17 | Angeion Group | |
| Health Enhancement Products, Inc. (N/K/A Zivo Bioscience, Inc.) | HEPI | 10/31/2003 - 5/31/2004 | 5/18/17 | Rust Consulting, Inc. | |
| Barclays Bank PLC (Electronic Foreign Exchange Trading - BARX) | n/a | 6/1/2008 - 4/21/2016 | 5/19/17 | Garden City Group | |
| EZCORP, Inc. | EZPW | 4/19/2012 - 10/6/2014 | 5/19/17 | Garden City Group | |
| King Digital Entertainment plc | KING | 3/26/2014 - 9/22/2014 | 5/23/17 | Gilardi & Co. |
| Elan Corporation, plc | ELN | On behalf of all persons: (i) who sold Elan Corporation, plc American Depositary Receipts contemporaneously defendants' purchases of Elan ADRs during the period August 23, 2006 through and including June 17, 2008 at 2:00 am EDT; and/or (ii) who purchased Elan ADRs, purchased call options thereon, or sold put options thereon, contemporaneously with the defendants' sales of Elan ADRs, sale of call options thereon, or purchases of put options thereon, during the period July 21, 2008 through and including July 29, 2008 at 4:00 pm EDT | 5/29/17 | A.B. Data, Ltd. | |
| PTC Inc. | PTC | 11/24/2011 - 7/29/2015 | 5/30/17 | Strategic Claims Services | |
| Revance Therapeutics, Inc. | RVNC | 6/19/2014 - 5/1/2015 | 6/5/17 | Gilardi & Co. | |
| Molycorp, Inc. | MCP | 2/7/2011 - 11/10/2011 | 6/14/17 | Gilardi & Co. | |
| CBD Energy Limited (n/k/a BlueNRGY Group Limited) | CBDE; CBDF | 6/13/2014 - 10/24/2014 | 6/29/17 | Strategic Claims Services | |
| Allco Finance Group Limited (Australia) | AFG | 8/21/2007 - 2/27/2008 | 6/30/17 | Maurice Blackburn | |
| Ampio Pharmaceuticals, Inc. | AMPE | 1/13/2014 - 8/21/2014 | 7/5/17 | Garden City Group | |
| FireEye, Inc. | FEYE | On behalf of all those who purchased FireEye, Inc. common stock in its March 6th, 2014 Secondary Public Offering | 7/8/17 | Kurtzman Carson Consultants | |
| Federal Home Loan Mortgage Corporation (SEC) | FRE; FMCC | 4/18/2000 - 6/8/2003 | 7/10/17 | Gilardi & Co. | |
| Altisource Portfolio Solutions S.A. | ASPS | 4/25/2013 - 12/21/2014 | 7/11/17 | Garden City Group | |
| Geron Corporation | GERN | 12/13/2012 - 3/11/2014 | 7/11/17 | Epiq Systems, Inc. | |
| Ruby Tuesday, Inc. | RT | 4/10/2013 - 10/9/2013 | 7/17/17 | Gilardi & Co. | |
| Third Avenue Focused Credit Fund | TFCVX; TFCIX | 3/1/2013 - 12/10/2015 | 7/19/17 | Gilardi & Co. | |
| L-3 Communications Holdings, Inc. (N/K/A L3 Technologies, Inc.) | LLL | 1/30/2014 - 7/30/2014 | 7/29/17 | Garden City Group | |
| Energy Recovery, Inc. | ERII | 3/7/2013 - 3/5/2015 | 8/4/17 | Garden City Group | |
| Dole Food Company, Inc. | DOLE | On behalf of all persons or entities who sold Dole Food Company, Inc.'s ("Dole" or the "Company") common stock (i) during the period from January 2, 2013 through October 31, 2013, inclusive, or (ii) on November 1, 2013 where those shares were sold on the open market and were not held as of the closing of the Take-Private Transaction. | 8/9/17 | JNG Legal Administration | |
| Halliburton Company | HAL | 8/16/1999 - 12/7/2001 | 8/12/17 | JND Legal Administration | |
| KBR, Inc. | KBR | 9/11/2013 - 7/30/2014 | 8/19/17 | Epiq Systems, Inc. | |
| DFC Global Corp. | DLLR | 1/28/2011 - 2/3/2014 | 9/4/17 | A.B. Data, Ltd. | |
| Sauer-Danfoss Inc. | SHS | 3/15/2013 - 4/12/2013 | 9/14/17 | Analytics, Inc. | |
| Covenant Partners, L.P. (SEC Fair Fund) | n/a | 1/1/1999 - 12/31/2014 | TBD | Securities and Exchange Commission | |
| FX Instruments (Canada) (UBS/BNP/Bank of America) | n/a | 1/1/2003 - 12/31/2013 | TBD | TBD | |
| Computer Sciences Corporation (SEC Fair Fund) | CSC | 8/5/2008 - 12/27/2011 | TBD | Garden City Group |